$2.05 -0.03 (-1.20%)
11/30/2009 12:24 PM

Corcept Therapeutics, Inc. (CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Featured Broker Partners